Research Topic · Peer-Reviewed

COVID-19 Vaccine

A COVID-19 vaccine is a biological preparation that induces protective immunity against SARS-CoV-2, the coronavirus responsible for COVID-19, thereby reducing the risk of infection and, more substantially, of severe disease. Multiple vaccine platforms have been deployed worldwide, including messenger RNA, viral-vect…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 9× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed June 2026

Overview

A COVID-19 vaccine is a biological preparation that induces protective immunity against SARS-CoV-2, the coronavirus responsible for COVID-19, thereby reducing the risk of infection and, more substantially, of severe disease. Multiple vaccine platforms have been deployed worldwide, including messenger RNA, viral-vector and inactivated whole-virus formulations, and their large-scale use has been central to the public-health response to the pandemic. Research on COVID-19 vaccines spans development, effectiveness, safety and the behavioural determinants of uptake. Studies in this journal's corpus examine vaccine hesitancy and the predictors of uptake in varied settings and populations, including healthcare workers and people living with HIV, reflecting the importance of acceptance for population-level protection. Other work addresses vaccine development insights and challenges, post-vaccination immune responses and seroprevalence, and the safety profile of specific products such as inactivated (Sinopharm/BBIBP-CorV) vaccines in particular patient groups. Case reports document rare adverse events affecting organs such as the liver and kidney following vaccination, while related analyses consider the molecular characterization of SARS-CoV-2 and the broader information environment, including the spread of misinformation. Together these aspects cover immunization strategy, real-world effectiveness, safety surveillance and the social context of vaccination.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373

How this research is being cited

The 12 articles above have been cited 9 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on COVID-19 Vaccine, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.